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Abstract 
Chinese hamster ovary (CHO) cell lines can fold, assemble and modify proteins post-
translationally to produce human-like proteins; as a consequence, it is the single most common 
expression systems for industrial production of recombinant therapeutic proteins. A thorough 
knowledge of cultivation conditions of different CHO cell lines has been developed over the last 
decade, but comprehending gene or pathway-specific distinctions between CHO cell lines at 
transcriptome level remains a challenge.  
To address these challenges, we compiled a compendium of 23 RNA-Seq studies from public and 
in-house data on CHO cell lines, i.e. CHO-S, CHO-K1 and DG44. Significantly differentially 
expressed (DE) genes particularly related to subcellular structure and macromolecular 
categories were used to identify differences between the cell lines.   
A R-based web application was developed specifically for CHO cell lines to further visualize 
expression values across different cell lines, and make available the normalized full CHO data 
set graphically as a CHO research community resource.  
This study quantitatively categorizes CHO cell lines based on patterns at transcriptomic level 
and detects gene and pathway specific key distinctions among sibling cell lines. Studies such as 
this can be used to select desired characteristics across various CHO cell lines. Furthermore, the 
availability of the data as an internet-based application can be applied to broad range of CHO 
engineering applications. 
 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1. Introduction 
Chinese hamster ovary (CHO) cell lines have been used as a cell line of choice for the production 
of the pharmaceutical proteins over the past few decades [1] owing to their ability to produce 
correctly folded and glycosylated proteins [2,3]. Studies [1] have shown that in 2014 around 
33% of all biopharmaceuticals produced and approved in the market were from CHO cell lines 
[4]. In recent years, a thorough understanding of how to optimize process parameters for 
individual CHO cell lines has been developed [2,5–7]. However, understanding the impact of 
genomic or pathway-specific differences between CHO cell lines at the transcriptome level (and 
ultimately proteome levels and phenotypes) remains a challenge. 
Earlier studies published in landmark publications [8–10] have unanimously shown that 
various CHO cell lines, such as CHO-K1, CHO-S and DG44, differ quite remarkably [11] in their 
geno- and phenotype, as CHO cell lines are highly variable and undergo hundreds of thousands 
of unique mutations over generations [12]. Such a group of related organisms when exposed to 
the same high mutational environment are formally called as “quasispecies” [8,13]. Similarly, 
CHO cell lines, that have a common ancestral background can be considered as a classic example 
of “quasispecies” on account of number of differences in their genotype. All of this contributes to 
the idea that several omics-based studies in the form of expression analysis, SNP analysis and 
copy number analysis should be performed with CHO datasets to further investigate the concept 
of quasispecies in the context of CHO cell lines. 
To begin to address this, and ultimately to gain cell line-specific understandings of modulation 
of given pathways and gene sets, we have analyzed 23 CHO cell line-specific RNA-Seq 
experiments. Most of the samples of cell lines used in the study were grown in batch culture and 
analysis was performed using an in-house developed pipeline. 
In this study, to distinguish the variation in the genes and pathways related to those genes being 
transcribed at mRNA level, expression analysis was performed across a broad range of CHO cell 
lines. Further, differential expression (DE) analysis was performed for various CHO cell lines 
within the same growth phase (i.e. either exponential or stationary). This revealed information 
about differences in the pathways in terms of cell morphology, cell structure and their 
molecular processes related to biological functions.  
Furthermore, in order to make RNA-Seq expression data readily available to the CHO 
community, we have developed a R-based web application. This allows all researchers 
independent of their computer skills to easily extract expression values of interest across the 
included 23 datasets. 
 
2. Materials and Methods 
The study was performed with a collection of 23 published RNA-Seq data of various CHO cell 
lines (CHO-K1, CHO-DG44 and CHO-S) obtained from three individual projects [12,14,15] are 
shown in (Supplementary Table 1). All of the RNA-Seq data was downloaded from NCBI in the 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
form of fastq files and securely stored on Computerome (a supercomputer for biological data 
analysis at the Technical University of Denmark). The Chinese hamster genome (PRJNA239316) 
i.e. sequence in .fasta format and annotation in .gff format, obtained from publication Lewis et al. 
“Genomic landscape of Chinese hamster ovary cell lines as revealed by the Cricetulus griseus 
draft genome” [16] was downloaded separately from NCBI to the server. Pictorial 
representation of entire data mining is shown in Figure1. 
 
2.1 Description of the samples 
Samples of CHO cell lines were selected from three different studies; two of these studies used a 
batch culture technique and the other cultured the cells in a 24-well plate. Samples of the CHO-S 
cell lines were identified from the work of Hefzi et al. [12] accession number NCBI GEO: 
GSE77800. This study demonstrated the construction of a genome-scale metabolic model for a 
variety of CHO cell lines, which can be used to predict growth phenotypes and known 
auxotrophies.  
Further, all CHO-DG44 samples, and one CHO-K1sample, were collected from the study by Lund 
et al., SRA accession number SRP073484. Here the study is mainly focused on reconstruction of 
the CHO secretory pathway, facilitated by mouse, yeast and human models [14].  
In addition, CHO-K1 samples were identified from the study by Wijk et al.[15], accession 
number PRJNA304606. This study describes the role of laminin alpha-2 (LAMA2), an 
extracellular matrix involved in the invasion of various human pathogens, i.e., how silencing of 
the LAMA2 decreases bacterial invasion, and vice versa. More detailed information about the 
description of the cell-line samples can be obtained from the corresponding manuscript. 
 
2.2 Summary of the RNA-Seq samples 
All RNA-Seq data was acquired from previous studies [12,14,15]. In summary, all CHO-S data 
points belonged to the same cell line, and samples for sequencing were taken at different time 
points. All CHO-DG44 samples were also taken from the same cell line. Out of four sample sets, 
two samples were cultured with non-essential amino acid (NEAA) solution and the other two 
samples were cultured with 0% NEAA solution. The data for the seven CHO-K1 samples were 
obtained from two different studies. One of the six data sample is linked to SRA accession 
number SRP073484 and the remaining six to accession number PRJNA304606. Even though the 
data was derived from two different studies, both were based on the ATCC CCL-61 cell line. 
For all three RNA-Seq studies, library generation was carried out using a TruSeq RNA sample 
preparation kit according to the manufacturer’s instruction, and sequencing was performed 
using the Illumina Hiseq 2500 platform. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.3 Quality check of raw reads and alignment pipeline 
A preliminary quality check was carried out using FastQC v0.11.5 
(http://www.bioinformatics.babraham.ac.uk/projects/fastqc/) in non-interactive mode, which 
allows systemic processing of a large number of the files and stores the results in permanent 
html records. According to the sequence quality score indicated by FastQC, quality trimming of 
the poor quality Illumina reads was performed using Trimmomatic v0.36 [17], adopting a 
paired-end mode as a sequencing mode and Phred +33 as a quality score. Alignment of all of the 
paired-end reads acquired from Trimmomatic, in relation to the Chinese hamster genome, was 
achieved using a STAR v2.5.2b aligner [18], choosing genomeGenerate mode as a runMode to 
generates genome indices using a genome FASTA file and GTF files that are then used to align 
the mRNA reads. Files obtained after alignment were converted into a binary version to reduce 
the size of the dataset, using SAMtools [19]. To count the gene feature of the reads in the form of 
read counts, all of the aligned reads were fed into an HTSeq v0.8.0 [20] package under 
intersection strict mode to filter those reads that were partially overlapping with the genomic 
feature. Here, an annotation file of the Chinese hamster genome in the form of a GFF file was 
also provided to the HTSeq to calculate the number of reads in the genes. Output from the 
HTSeq package generated in the form of text was downloaded from the server and loaded into 
RStudio v0.99.1261 (https://www.rstudio.com/), with the integrated development 
environment running on R v3.3.3 [21] for performing further downstream analysis. 
 
2.4 Differential expression analysis pipeline  
All feature count files were merged into one file to be processed in matrix form. Initially, the 
matrix count file contained the information for all genes in the CHO genome. Through an 
examination of the logCPM value, we found that a large proportion of the genes within 
individual samples were unexpressed (Supplementary Figure 1A). Hence, we chose to retain a 
CPM value of 1 [22] as a cutoff in our analysis as it distinguished expressed genes from 
unexpressed genes for most of the dataset (Supplementary Figure 1B). Subsequently, all genes 
with a CPM of 1 (i.e., 25 reads if the library size is 25 million) or above in at least two samples 
(Filter) were retained for further downstream analysis (Figure 1).  
Consequently, all feature counts were stored in the DGEList object. Next, the genes were 
normalized by using TMM algorithms [22,23] and the calcNormFcator function of edgeR [24,25]. 
To evaluate the normalization, library sizes of the sample sets were compared before and after 
performing normalization. Supplementary Figure 2 shows the adjusted library size pre- and 
post-normalization, while Supplementary Table 2 shows the read count of the sample-specific 
library size along with its pre- and post-normalized normalization factor. Subsequently, to 
establish the mean variance relationship in the data to calculate weights based on the calculated 
mean variance, we used the relationship function voom [26] from the limma [27] package. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Transformation of the RNA-Seq data for linear modeling was performed using the lmFit 
function of limma. Consequently, differentially expressed (DE) genes were determined with the 
limma lmFit function. Finally, differential expression analysis was performed using an empirical 
Bayes model (eBayes) [27]. Moderated t-statistics and the log-odds ratio was calculated using a 
design and matrix and a contrast matrix. Summaries of the gene sets were laid out by various 
functions such as toptable and volcanoplot [28] to finally determine the highly differentially 
expressed genes in each of the contrasts.  
 
2.5 Gene set enrichment analysis pipeline 
The Piano [29] package was used to perform gene set enrichment analysis. The analysis was 
performed for all of the categories of the gene ontologies, i.e., cellular component (CC), 
biological process (BP) and molecular function (MF). Human and mouse gene sets belonging to 
the CC, MF and BP categories of gene ontology [30] were downloaded from the Molecular 
Signature database (MSigDB) [31] database and GO2MSIG[32]. All of CHO gene symbols were 
converted to human and mouse symbols by performing reciprocal best BLAST hits in relation to 
the CHO genome with human and CHO genome with mouse. Following this, calculation of the 
consensus score [29] was performed by taking the mean of seven statistical scores (mean, 
median, sum, maxmean, fischer, stouffer, and tailstrength) to calculate the gene set statistics 
available in the package. All the statistics were combined and analyzed in the form of a heatmap, 
to identify and verify up-regulated and down-regulated pathways, as consensus scores of 
pathways belonging to all of the contrasting categories of CC, MF and BP varied between 
comparisons. To maintain consistency across of all of the combinations, the consensus scores 
for all four combinations were merged into one table. Next, a filtration of highly up-regulated 
and highly down-regulated pathways was performed based on up-regulation of distinct 
directional classes, as the distinct directional class was visually found to be highly consistent 
with other classes of the multi-directionality class. For picking highly up-regulated and down-
regulated pathways of BP category, all of the pathways belonging to the consensus score <2 and 
>2600 were taken. To identify up-regulated and down-regulated pathways in the MF category, 
consensus scores of <15 and >300 were selected, while score of  <10 and >200 were adopted for 
the CC category. The same cutoffs were used for both human and mouse categories.  
 
2.6 Definition of contrasts for differential expression analysis 
Differential expression analysis was performed between samples of the various CHO cell lines 
from different growth phases. Growth phases were allocated according to the original study 
where available, by examining the data of the original study, or, where applicable, by assuming 
that transition of the CHO cells from the exponential phase to the stationary phase takes around 
4 days. In summary, all samples taken before 96 hours were assigned to the exponential phase, 
while the remaining samples were assigned to the stationary phase. Samples were picked 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
randomly and we then compared differential expression patterns across samples relating to the 
exponential phase and stationary phase for all of the cell lines.  
  
2.7 Usage of R-shiny for developing a R-based web application 
Datatable v0.2, a javascript library, was used in shiny v1.0.3 to develop a R-based web 
application CHO Gene Expression Visualization Application (CGEVA) that was made available to 
users by sending a client-side processing request to server-side processing.  
 
3. Results and Discussion 
3.1 Data Compendium Assembly 
To create a catalog of gene expression across the cell lines and experimental conditions, 23 CHO 
RNA-Seq samples were used, covered by 23 runs (Supplementary Table 1), collected from three 
different studies [12,14,15] from the NCBI database as fastq-files. The data was selected solely 
from RNA-Seq studies so as to maintain data consistency. We chose to focus on RNA-Seq data to 
exploit the greater sensitivity of the RNA-Seq data and to retain the ability to discriminate 
regions of high-sequence identity. 
 
All of the CHO-S cell lines used in the study were parental cell lines taken at 72, 84, 96, 132, 144 
and 156 hours, whereas all of the CHO-DG44 cell lines used in the study were producer cell lines 
taken at 48, 130 and 140 hours. Further, of the seven CHO-K1 samples, one was parental cell 
line taken at 24 hours and the remaining three were cultured in 24-well plates. However, the 
study did not record the exact time when the samples were taken from the 24 well plates. A 
detailed description of all the samples and their respective cell lines is provided in 
Supplementary Table 2. 
To ensure quality and comparability across experiments, multiple quality checks were 
performed followed by RNA-Seq analysis. Expression values obtained in the form of gene 
feature counts after aligning the reads to the Chinese hamster genome were normalized and log 
transformed and loaded into a R-based web application to make the information available as a 
community resource. This is explained thoroughly in the later part of this section.  
 
3.2 Initial RNA-Seq QC to eliminate sequencing noise  
To exclude the data noise incurred by the sequencing machine in the form of sequencing bias, 
contaminations, and low-quality regions that may have impacted the interpretation of the 
downstream analysis [33], RNA-Seq quality control was performed on the raw data, using 
FastQC report. Further, trimming of the reads either from the beginning or at the end was done. 
Only sequences of the good quality were used for further analysis.  
 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.3 Alignment of RNA-Seq data to Chinese hamster genome 
The percentage of uniquely mapped reads to the reference genome or transcriptome is an 
overall indicator of the sequencing quality. Hence, an alignment summary for each file is shown 
in Supplementary Table 2. The data shows that the percentage of the aligned reads varied 
between 73% and 88% across all of the samples, indicating that an adequate amount of reads 
had been mapped to the genome. In previous studies [34–36], 70–90% of the total RNA-Seq 
reads were found to be mapped to the human genome. This suggests that this data set was of a 
similar and sufficient quality. 
 
3.4 Summary of read counts QC obtained after alignment 
Library size or depth is an indicator of the number of the reads sequenced for a given sample. A 
higher library size allows a more precise quantification of reads as it is sequenced to a deeper 
level. Hence, to examine the quality of the library size, the number of reads per sample was 
inspected (Supplementary Figure 3) and found to be greater than 23 million [37,38], implying 
that the read depth was of sufficient quality to be used for further downstream analysis. 
 
3.5 Quality Check to observe the variation between various CHO cell lines  
Multidimensional scaling (MDS) is an efficient way to visualize the variability in a dataset and 
can be used as a QC measure to check the extent of anticipated differential expression and to 
examine variability within replicates and groups of experiments. For this reason, an MDS plot 
was generated to visualize the similarity across all of the samples, as shown in Supplementary 
Figure 4. In this plot, the distance between each pair of the samples was considered as a root-
mean-square deviation of the top 500 genes. Also, the distances shown on the plot can be 
interpreted as leading log2-fold change between samples of the genes that distinguishes those 
samples. Considering the value of logFC on first as well as on the second dimension of the MDS 
plot, it can be seen from the figure that the samples of the same cell line are grouped together as 
compared to the samples of the other cell lines. This initial plot suggests that the cell line might 
be the largest differentiating effect between the samples. However, since the cell lines 
originating from experiments conducted in different laboratory setups, this may also be an 
effect of the individual experimental setups. With the same caveat, our analysis also implies that 
among all three-cell lines, CHO-K1 is most variable than the other two cell lines. 
  
3.6 Normalization of the datasets to make them more comparable to each other  
RNA-Seq data sets are normalized to minimize the effect of the technical bias and to achieve a 
more precise measurement of the differentially expressed genes. To achieve this, we have 
performed TMM (Trimmed mean of M-values) normalization on our RNA-Seq dataset as a first 
layer of normalization to eliminate any composition bias and make the dataset comparable to 
each other. Subsequently, we estimated the voom variance relationship to further address the 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
variation in precision between different observations, and then used an eBayes (empirical 
Bayes) approach to estimate the weights between samples.  
Studies [22] have shown that for RNA-Seq count data, the mean is dependent on variance and 
its relationship is established by precision weight calculated by voom, as shown in 
(Supplementary Figure 5). Typically, a voom plot shows a decreasing trend between the log 
count mean variance relationship resulting from various technical and biological variations in 
the sequencing between the replicate samples from different cell populations. Hence, to show 
the mean-variance relation of each individual gene across all of the samples included in the 
study, the log2mean value of the gene was plotted against its standard deviation on the y-axis 
(Supplementary Figure 5), illustrating the expected decrease in the standard deviation with 
increase in the count size. Specifically, a sudden decrease in the standard deviation was 
observed with increase in the count size of more than approximately 32 (log2 (count size + 0.5) 
= 5). Moreover, this plot is very useful in providing visual checks on the filtering carried out 
upstream, i.e. if the filtering of the lowly expressed genes is insufficient for the purpose of 
performing DE analysis, or else a drop in the variance level is observed at the low level of the 
trend.  
An illustration of the effect of normalization and transformation of the dataset can be seen in 
(Supplementary Figure 2). Specifically, in the post-normalized count, a comprehensive skewed 
median of log2CPM can be observed as compared to the un-normalized log2CPM, to support the 
transformation of the normalized data. This pattern indicates a consistent distribution of the 
expression values that will facilitate more meaningful investigation of the DE genes.  
Furthermore, all normalized log count per million values of each differentially expressed genes 
were loaded into an application created using a Shiny and R-based web application framework, 
as described in detail in a Section 3.11. 
 
3.7 DE analysis for examination of possible cell line-specific traits 
To understand the differences between the expression levels of the processes driven by 
pathways over various culture conditions, we performed differential expression analysis in two 
steps: a definition of contrasts, and a statistical analysis. 
 
3.8.1 Defining contrasts for differential expression analysis: Comparing the expression 
levels of genes is essential for identifying possible differences between CHO cell lines 
(quasispecies). In particular, we were interested in looking for trends at the level of subcellular 
structures and macromolecular complexes. As the cell lines were collected from various 
different laboratories, it was difficult to comment on the BP and MF categories, we therefore 
chose to focus on the CC category to identify organelle-level differences. Also, by comparing CC 
categories between cell lines, we have tried to emphasize the inherent morphology of the 
anatomical structure. To accomplish this, a differential expression analysis was performed on 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
normalized gene feature counts ultimately to determine quantitative changes in expression 
levels between experimental groups. The contrasts for the statistical analysis were defined as 
indicated in Figure 1. As can be seen from the contrast, three-way comparisons were performed 
separately across all samples between samples of exponential phase of CHO-S with CHO-K1, 
CHO-S with CHO-DG44, and CHO-K1 with CHO-DG44 separately. For samples from the 
stationary phase, all possible comparisons were performed between CHO-S and CHO-DG44 
samples because of the unavailability of stationary phase data relating to CHO-K1. Comparison 
of contrast between all of the comparisons is illustrated in Figure2. Essentially, this procedure 
aimed to identify cell-line differences that were consistent across growth phases.   
     
3.8.2 Statistical Analysis: Differential expression analysis was performed with the aid of 
contrast on 14619 genes obtained after filtering genes with low expression levels. A p-value of 
<0.05 was used to identify genes considered to be significantly differentially expressed. To 
estimate the number of highly differentially expressed (DE) genes across the various cell lines 
over growth phases, we applied a cutoff on an absolute logFoldchange (lfc) of 1(Table1). 
However, all genes obtained after applying the filter of p<0.05 were taken ahead for 
downstream analysis to observe an overall effect of the significantly DE genes. Further, 
visualization of the association of DE genes between CHO-S and CHO-DG44 was shown with the 
help of volcano plot plotted between lfc and logOdd ratios shown in Figure 2. Highly up-
regulated and down-regulated genes are shown towards the left and right side of the graph in 
the form of black dots for all contrasts. In addition, statistical values of all of the DE genes in 
terms of log fold change, average expression, t-value, p-value and adjusted p-value can be 
looked up for individual genes for all contrasts in Supplementary Tables 3.1-3.4. 
  
3.9 Gene set enrichment analysis (GSEA) to observe the comparative results of various 
cell lines  
Differential expression (DE) analysis is a common way to depict the manifestation of the states 
of two distinct cell lines. Hence to identify the differences between CHO cell lines belonging to 
the same growth phase, DE was performed. Hereafter, GSEA was performed between multiple 
samples of the same growth phase to examine the pathways associated with significantly 
differentially expressed genes. Individual gene comparisons were made available to the 
community through a web-based app with a graphical user interface (see below). GSEA was 
performed with the aid of a R-based package, Piano, which can calculate a consensus score 
based on the rank aggregation for each directionality class. Further, Piano has three kinds of 
directionality class: distinct-directional, mixed-directional and non-directional. In distinct 
directionality, the p-value is calculated by cancelling the effect of up-regulated and down-
regulated gene sets, whereas in mixed directionality, the p-value is calculated according to the 
subset of the genes that are up-regulated or down-regulated respectively. Moreover, in the non-
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
directional class, the p-value is calculated by taking the absolute value of the gene statistics. 
Hence, we interpreted the cell line-specific traits from heatmaps ranked according to data 
obtained from all of the three directionality classes. As Piano allows the integration of existing 
biological knowledge into the expression analysis, we compared contrasts of the DE genes with 
the aid of pathways obtained from heatmaps, taking comparison between various contrasts of 
the DE genes. We initially worked with the human data, as this gave access to some well-
annotated networks of function (e.g. apoptosis etc). To substantiate our results, we used the 
mouse genome to perform the same analysis, and the results were found to be concordant. 
 
3.10 Cell line specific trait portraying cellular transcriptomic signatures of CHO 
quasispecies 
When comparing CHO-S with CHO-DG44, as illustrated in Figure 3, we have observed higher 
expression levels for the pathways related to the components of the Golgi apparatus, endosome 
and vacuole in CHO-S cell lines than in CHO-DG44 cell lines. Further, a similar result was 
observed when CHO-S was compared with CHO-K1, and CHO-DG44 was compared with CHO-
K1. Conversely, a down-regulation in the expression level of the elements and processes related 
to the ribosome and the mitochondrion was observed for CHO-S over CHO-DG44, and for CHO-
K1 and CHO-DG44 over CHO-K1, when compared to each other (additional comparisons can be 
found in Supplementary Figure 6.1-6.23) (Supplementary Table 4.1-4.12). In other words, 
differential expression of the gene sets involved in the pathways related to the cellular 
component category of one cell line was found to be the same when compared with other cell 
lines, irrespective of the time points. 
 
3.10.1 Description of cell line-specific traits 
Clearly as stated earlier, given the nature of the data, the possible cell-line specific effects may 
be contrasts between experimental setups, media, or other parameters used for cultivation. 
However, since it is generally known in the field that cell lines display very different properties, 
and genome sequences support substantial differences between cell lines at the genomic level 
[16], we wanted to examine in more depth whether any cell-line specific effects would also be 
found in comparisons. We were particularly interested in determining whether there were any 
significant differences in organelle-specific processes, but to avoid overlooking other trends, we 
also included molecular process and biological function in the analysis. Overall, we assumed 
that overexpression of genes associated with certain organelles or processes directly or 
indirectly measures the relative importance of that organelle or process in a specific cell line 
compared with another cell line. Similarly, up-regulation of genes involved in the relevant 
biological process, or genes associated with the organelles hosting those processes, indicates 
that the mass or number [39] (in case if they are found in abundance in a cell) of that particular 
organelle is up regulated. Up-regulation occurs either as a result of biological perturbation 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
leading to enhanced activity of the particular process or as a result of the inherent nature of that 
particular cell line. To examine the same behavior between cell lines, a thorough analysis of 
each contrast was performed. Following this, we examined pathways specifically linked to 
subcellular structure and macromolecular complexes of cellular component category, along 
with biological processes and molecular function of gene ontology (GO), of both human and 
mouse. 
For the analysis of the GO cellular component, pathways related to the organelles such as the 
golgi complex, endosome, lysosomes and vacuoles were observed to be up-regulated in CHO-S 
relative to CHO-DG44/CHO-K1 (Figure 3), suggesting a higher expression level of a late protein 
secretion pathway such as packaging and transportation of the protein than in the other cell 
lines. However, up-regulation of organelles, such as the mitochondria, the ribosome and various 
components of the splicing apparatus (e.g. the spliceosome, U1-U5 SNRNP’s, methylosome and 
cajal body) in the CHO-DG44 and CHO-K1 cell lines as compared to the CHO-S cell lines, suggests 
that these cells have a higher expression level of the early transcription and post-transcriptional 
modifications.  
When we examined the GO molecular function category, we observed up-regulation of 
demethylase enzyme, that is important in epigenetic modification mechanism in CHO-S cells 
compared with CHO-DG44 and CHO-K1. Further, in the same comparison peptidyl transferase 
that is an aminoacyltransferase involved in peptide bond formation during the translation 
process of protein biosynthesis was observed. Similarly, several kinase activities in the form of 
protein kinase and kinase-binding signifying phosphorylation, were also observed. However, we 
observed down regulation of the G-protein coupled receptor, GTPase regulator, Wnt protein 
binding, serine hydrolase, serine type endopeptide, ribosome binding and myosin binding 
obtained from molecular and biological processes under the same comparisons, clearly 
indicating analogy with the results obtained in our analysis of the cellular components. 
 
Furthermore, in an analysis of the biological processes for the GO category, we observed up-
regulation of pathways in relation to the aminoglycan metabolic process, carbohydrate 
metabolic process, endocytosis, fatty acid metabolic process, GPCR signaling pathway, 
regulation of secretion, and the vascular endothelial growth factor receptor signaling pathway, 
and down regulation of the pathways in relation to, for example, amino acid activation, 
maturation of ribosomal RNA, mitochondrial organization, and respiratory chain complex 
assembly, the organonitrogen compound biosynthetic process, post-transcriptional activation of 
gene expression, regulation of RNA splicing, ribosome assembly and biogenesis. 
As a consequence, the overall analysis indicates that over exponential phase CHO-S cell lines 
were more inclined toward post-translational modification and secretion of the protein than 
exponential phase CHO-K1 and CHO-DG44 cell lines. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Furthermore, this study can also be viewed to illustrate the role of the components of the 
secretory pathway, working end-to-end to progress the process of secretion of the protein over 
various CHO cell lines. In other words, genes generally responsible to progress the main 
components of the secretory pathways, e.g.. Golgi apparatus, endoplasmic reticulum, 
endosomes, and vacuoles were found to be up-regulated in the CHO-S cell lines compared with 
the CHO-K1 and CHO-DG44 cell lines, implying that the secretory pathway [40,41] is more 
active in CHO-S than in CHO-K1 or CHO-DG44.  
As a counterpoint, the observed results could also be explained by a possible higher cellular 
weight or by the fact that the density of the cell organelle present in CHO-S was observed to be 
greater than that present in CHO-DG44 and CHO-K1 [39]. Similar results were observed when 
CHO-DG44 was compared with CHO-K1. In other words, all of these comparisons have 
suggested that up-regulation in the expression value of the golgi apparatus, endosomes, 
lysosomes and vacuole might be due to the greater cellular mass/density of CHO-S as compared 
to CHO-K1 and CHO-DG44. And a similar analogy applies when comparing CHO-DG44 with CHO-
K1 irrespective of the time point at which it was collected in the batch culture. In summary, with 
the help of this analysis, assuming that the observed differences were indeed due to cell line-
specific variation, we can assert that theoretically, CHO-S may potentially be the best general 
host for the production of secreted protein, although this conclusion is based solely on 
transcriptomic datasets. However, a prediction of best cell lines greatly depends from 
application to application and the compatibility of the proteins which need to be produced. 
The results of the GO analysis are interesting in the light of previous studies for e.g. study by Sha 
et al. [42] demonstrated that CHO high producers expresses high amount of genes related to 
secretion and protein transportation. Further, work by Clark et al [43] performed on  CHO-K1 
and CHO-DUX producer cell lines indicated that the rate limiting step in the secretion of the 
protein might lie in the translational and post-translational processes. In particular, the genes 
APP and MAPK1, which have been extensively linked to the protein secretion, were also found 
to be significantly differentially upregulated in our study and the aforementioned study. 
Another interesting insight that has been found to correlate with an earlier study [44] is finding 
that differential expression of the genes associated with the golgi vesicle, secretion, secretory 
pathway, vesicle-mediated transport and the core component of the ribosome was observed in 
relation to temperature shifts in CHO cultures. These findings are similar to the results we 
observed when various CHO cell lines were compared with each other. Thus, it appears that 
there are general differences between the cell lines, which could be linked to organelle sizes, 
activities and the secretory capacities of the cell lines.  
 
However, to further support the findings of the present analysis, experimental verification of 
the results, for instance cell line specific ultracentrifugation [45], would be required via 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
fractionation of the cells and isolation of the individual organelles. This would allow us to draw 
firmer conclusion about the sizes of the organelles observed in the analysis. 
 
3.11 A graphical interface for simple access to the RNA-Seq compendium 
Generally, it is a problem that most omics data is primarily used in the original publication and 
not exploited sufficiently for other uses. One contributing factor to this unfortunate trend is the 
publication and storage of sequencing data as raw data files, which are inaccessible to many 
researchers not familiar with assembly, mapping, and annotation algorithms. For this reason, 
we have prepared a simple, yet powerful R-based web application “CGEVA” to retrieve the 
normalized data from this compendium, which will be expanded as more CHO RNA-Seq 
experiments are published. 
The interface of CGEVA (https://anksi.shinyapps.io/biosciences/) allows multiple access and 
analysis modes (Figure 4). Datasets for each cell line are found in different tabs. Within each tab, 
each column shows normalized log2-transformed CPM values at various time points (samples) 
of each genes represented in rows. Further, columns-wise sorting of the expression values can 
be performed either in increasing or decreasing order, thus making it simple to find highly 
expressed or inactive genes. Additionally, a gene of interest can be searched from the search box 
menu, which may be of useful to researchers involved in genetic engineering of CHO cells. The 
interface also shows a sample-specific boxplot combining the expression values of each sample, 
which dynamically adapts to show the expression value of search results, when a new term is 
selected from the search menu, thus making it easy to quickly examine transcription profiles of 
genes of interest. Finally, all expression values can be downloaded by clicking the print button 
located in the left-hand corner of the main panel of the application, which exports both the full 
dataset and the search results. The scripts for the app can also be made available as a 
community resource, should the user wish to load in their own in-house data. We thus hope that 
this can facilitate increased use and dissemination of existing as well as future, datasets. 
 
4. Conclusions and closing remarks 
 
DE analysis performed followed by GSEA from transcriptomic data of various CHO cell lines 
suggests that being in the exponential and stationary phase CC pathways related to the 
organelles such as the golgi complex, endosome, lysosomes and vacuoles were observed to be 
up-regulated in CHO-S relative to CHO-DG44/CHO-K1. Similar trends were observed in the 
pathways of MF category where pathways related to demethylase enzyme, peptidyl transferase 
and various kinase activities were found to be up-regulated in the same comparison. Besides, in 
BP category, we observed up-regulation of pathways in relation to the aminoglycan metabolic 
process, carbohydrate metabolic process, endocytosis, fatty acid metabolic process, GPCR 
signaling pathway, regulation of secretion, and the vascular endothelial growth factor receptor-
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
signaling pathway. Binding enrichment analysis of all three GO category together led us to 
conclude that CHO-S followed by CHO-DG44 and CHO-K1 contains efficient machinery apt for 
carrying out post-translational modification and the secretion of the protein. That may be the 
result of several factors, such as size, density of the cell organelle, or regulation of the processes 
taking place inside the cells. To validate this analysis, various in vitro analyses, e.g., secretion 
assays or ultracentrifugation, need to be performed.    
Another interesting aspect of this study was the development of our R-based web application 
CGEVA. The main idea behind developing such an app was to make the information of the study 
readily available as a resource to those working in the a CHO related field. As with most of the 
RNA-Seq studies published online, deposition of the raw sequences in the form of fastq or sra 
files is routinely performed. As a result, it can be very challenging for the experimental biologist 
to handle these data formats. Further, it may cost a significant amount of time and money to 
replicate some of these studies as handling and processing of the huge “omics” data requires an 
adequate amount of time and resources in the form of efficient servers. Hence, this application 
is data independent, such that any type of RNA-Seq data that was aligned to the reference and 
counted for its gene feature counts can be fed into this app and visualization for the gene feature 
counts across all of the samples can be performed.  
Besides, with the help of this application, we have tried to overcome the difficulties faced by the 
experimental biologist in deciphering RNA-Seq datasets. As the information provided in the 
form of htseq count can be interpreted by: 1) experimental biologists, (e.g. for targeting the 
genes present in a specific pathway), 2) researchers using in silico methods for pathway 
modeling, (as in the work by [12]), to pick most transcribed enzymes to build their model on, 
and 3) computational biologists wanting to start their analysis directly from the normalized 
data, rather than having to invest weeks of computing time for mapping and normalizing data. 
At the same time, we call for the scientific community to conduct more studies of this kind with 
the aim of making data comprehensive and easily accessible to the community. 
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Table 
Table 1. Number of significantly differentially expressed genes 
Table illustrating number of significantly differentially upregulated, not expressed, down 
regulated and total number of genes in columns at Pvalues < 0.05 and lfc =>1 of various cell line 
specific comparisons. First row of the contrast is showing the comparison performed between 
all of the samples of CHO-S cell line with the entire sample of CHO-DG44 cell line. Second row, 
comparison performed between all of the samples of CHO-S with all of the samples of CHO-K1 at 
exponential phase. Third row, between all of the samples of CHO-DG44 and CHO-K1 and fourth 
row between CHO-S and CHO-DG44 at stationary phase. 
P<0.05: P value less than 0.05, lfc=1: Log fold change value is equal to 1, Down: downregulated 
gene sets, NE: Not differentially expressed gene sets, Up: upregulated gene sets, Total: total 
number of gene sets 
 
 
 P<0.05 lfc=>1 
Contrast Down NE Up Down NE Up 
 -1 0 1 -1 0 1 
SExp1all.DExp1all 5397 4554 4655 4865 5736 4005 
SExp1all.KExp1all 5764 3432 5410 5491 3955 5160 
DExp1all.KExp1all 4324 5265 5017 3937 6011 4658 
SStat1all.DStat1all 5212 5116 4278 4644 6290 3672 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figures 
Figure 1. Data mining decision tree  
Schematic representation of the overall data mining decision tree is depicted in the left 
flowchart. Right flowchart is depicting the elaborated schema of part of the left flowchart. 
Depiction of two main output is shown with blue box. 
 
Figure 2. Volcano plot showing significantly differentially expressed genes in the form of 
black dots. Plot is drawn taking log fold change value on x-axis and log odds ratio on the y-axis. 
Red line over x-axis is separating genes with log fold change between -7:+7 and over y-axis is 
separating genes with log odds 10 or above to others. Comparison made between the samples 
sets of cell lines are A) CHO-S and CHO-K1 B) CHO-S and CHO-K1 exponential phase C) DG44 
and CHO-K1 exponential phase D) CHO-S and DG44 stationary phase. 
  
Figure 3. Heatmap representation of topmost differentially expressed pathways 
comparing CHO-S and DG44 taking cellular component category of gene ontology. Column 
of the heatmap is representing consensus score obtained from multiple results object of the 
runGSA function of Piano. Furthermore, gradient of colour from red to yellow is indicating 
decrease in the consensus score representing change in the gradient from up regulated to down 
regulated pathways. In the heatmap, first and fifth columns are representing down regulation 
and up regulation of pathways of distinct directionality class respectively. Further, second and 
fourth columns of the heatmap are indicating mixed directionality of up regulated and down 
regulated genes. Middle column of the heatmap is indicating non-directional class.  
 
Figure 4. Pictorial representation of CHO Gene Expression Visualization Application. Main 
part of the figure is showing alphabetically sorted genes along with their normalized log 
transformed expression count of DG44 tab. Samples used in the study are separately shown in 
columns. Second half of the figure is representing bar plot showing median along with upper 
and lower quartile of the expression counts per column i.e. separately for each sample. Towards 
the leftmost part small description of the CHO cell line along with the link are shown that can be 
used to cite the manuscript.     
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